Search

Your search keyword '"José Marcelino Aragão Fernandes"' showing total 3 results
Start Over Author "José Marcelino Aragão Fernandes" Topic neurosciences. biological psychiatry. neuropsychiatry
3 results on '"José Marcelino Aragão Fernandes"'

1. Myasthenia gravis in Ceará, Brazil: clinical and epidemiological aspects

Author

Aline de Almeida Xavier Aguiar, André Ferrer Carvalho, Carlos Mauricio de Castro Costa, José Marcelino Aragão Fernandes, José Artur Costa D'Almeida, Luís Edmundo Teixeira de Arruda Furtado, and Francisco Marcos Bezerra da Cunha

Subjects
miastenia grave, avaliação clínica, epidemiologia, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Abstract

A retrospective chart review was performed on patients diagnosed as having myasthenia gravis in Ceará State, Brazil and who were followed from October 1981 to June 2009. Clinical and epidemiologic aspects were evaluated. In this work, 122 patients were studied, of whom 85 (69.7%) were females and 37 (30.3%) were males. The disease duration ranged from five months to 50 years (8.9±8.1 years). Age at the first symptoms varied from 0 to 74 years (31.9±14.4 years). The first main symptoms and signs were ptosis, diplopia and limb weakness. Generalized myasthenia was the most common clinical presentation, but 5.1% (n=6) persisted as ocular myasthenia. Thymectomy was performed in 42.6% (n=52) of myasthenic patients. A thymoma was present in 10 patients. Serum acetylcholine receptor (AChR) antibodies were present in 80% (n=20) of specimens tested. The data presented are similar to those of studies performed in other countries.

Published
2010
Full Text
View/download PDF

2. Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A

Author

José Marcelino Aragão FERNANDES, Francisco de Assis Aquino GONDIM, Antônia Maria Negreiro DIAS, Rosângela de Albuquerque RIBEIRO, Luiz Ivando Pires FERREIRA FILHO, and Vicente de Paulo Teixeira PINTO

Subjects
Hemophilia A, Intracranial Hemorrhages, Peripheral Nervous System Diseases, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Abstract

ABSTRACT Background: Bleeding in hemophiliacs can cause complications in the central and peripheral nervous system (CNS and PNS). The incidence of intracranial hemorrhage has reduced after the introduction of prophylactic treatment with factor VIII or IX, but the benefits of this therapy have not yet been evaluated on PNS complications. Objective: The aim of this study was to determine the prevalence of neurological complications in hemophiliacs and verify the effect of prophylactic therapy in these patients, including PNS disorders. Methods: We retrospectively evaluated the prevalence of CNS and PNS disorders caused by bleeding in hemophiliacs seen at the Hemocentro Regional Norte, Ceará, Brazil, from 1992 to 2018, and we compared the incidence in different periods (before and after the introduction of prophylactic treatment in 2011). Results: Of 75 hemophilia A patients evaluated (4.61/100.000 population), 13.3% (n=10) had either CNS (n=5) or PNS (n=5) disorders secondary to bleeding. Patients submitted to factor VIII replacement prophylactic therapy were less likely to have CNS events: from 1992 to 2011, 5 of 63 patients had CNS disease, while from 2011 to 2018, there were no new cases (p=0.0181). From 2011 to 2018, 5 PNS events occurred in patients without prophylactic therapy, whereas none occurred in those covered by prophylactic therapy (5/20 versus 0/29, p=0.0081). Conclusions: The prevalence of neurological complications in hemophiliacs in our cohort is similar to other studies. Similar to CNS, prophylactic therapy also reduces the risk of PNS complications. This is the first report in the literature showing this benefit.

Full Text
View/download PDF

3. Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A

Author

José Marcelino Aragão Fernandes, Vicente de Paulo Teixeira Pinto, Francisco de Assis Aquino Gondim, Rosângela de Albuquerque Ribeiro, Luiz Ivando Pires Ferreira Filho, and Antônia Maria Negreiro Dias

Subjects
Central Nervous System, Pediatrics, medicine.medical_specialty, Intracranial Hemorrhages, Population, Doenças do Sistema Nervoso Periférico, Hemorrhage, Neurosciences. Biological psychiatry. Neuropsychiatry, Hemophilia A, Peripheral Nervous System, medicine, Humans, In patient, education, Retrospective Studies, education.field_of_study, Factor VIII, business.industry, Incidence (epidemiology), Hemorragias Intracranianas, Peripheral Nervous System Diseases, Hemofilia A, medicine.anatomical_structure, Neurology, Peripheral nervous system, Cohort, Neurology (clinical), Cns disease, Nervous System Diseases, business, Brazil, Prophylactic treatment, RC321-571
Abstract

Background: Bleeding in hemophiliacs can cause complications in the central and peripheral nervous system (CNS and PNS). The incidence of intracranial hemorrhage has reduced after the introduction of prophylactic treatment with factor VIII or IX, but the benefits of this therapy have not yet been evaluated on PNS complications. Objective: The aim of this study was to determine the prevalence of neurological complications in hemophiliacs and verify the effect of prophylactic therapy in these patients, including PNS disorders. Methods: We retrospectively evaluated the prevalence of CNS and PNS disorders caused by bleeding in hemophiliacs seen at the Hemocentro Regional Norte, Ceará, Brazil, from 1992 to 2018, and we compared the incidence in different periods (before and after the introduction of prophylactic treatment in 2011). Results: Of 75 hemophilia A patients evaluated (4.61/100.000 population), 13.3% (n=10) had either CNS (n=5) or PNS (n=5) disorders secondary to bleeding. Patients submitted to factor VIII replacement prophylactic therapy were less likely to have CNS events: from 1992 to 2011, 5 of 63 patients had CNS disease, while from 2011 to 2018, there were no new cases (p=0.0181). From 2011 to 2018, 5 PNS events occurred in patients without prophylactic therapy, whereas none occurred in those covered by prophylactic therapy (5/20 versus 0/29, p=0.0081). Conclusions: The prevalence of neurological complications in hemophiliacs in our cohort is similar to other studies. Similar to CNS, prophylactic therapy also reduces the risk of PNS complications. This is the first report in the literature showing this benefit. RESUMO Antecedentes: O sangramento em hemofílicos causa complicações no sistema nervoso central e periférico (SNC e SNP). A incidência de hemorragia intracraniana diminuiu após a introdução da profilaxia com fator VIII ou IX, entretanto esse benefício ainda não foi avaliado no SNP. Objetivo: O objetivo deste estudo foi determinar a prevalência de complicações neurológicas em hemofílicos, verificando o efeito da terapia profilática também no SNP. Métodos: Avaliamos retrospectivamente a prevalência de complicações neurológicas causadas por sangramentos em hemofílicos atendidos no Hemocentro Regional Norte, Ceará, Brasil, de 1992 a 2018, comparando a incidência em diferentes períodos (antes e depois da introdução do tratamento profilático em 2011). Resultados: Foram avaliados 75 pacientes com hemofilia A (4,61/100 mil habitantes). Deles, 13,3% (n=10) tinham distúrbios do SNC (n=5) ou do SNP (n=5) secundários a hemorragias. Os pacientes submetidos à terapia profilática com fator VIII apresentaram menor probabilidade de eventos do SNC: de 1992 a 2011, cinco de 63 pacientes apresentaram hemorragia no SNC, enquanto de 2011 a 2018 não ocorreram novos casos (p=0,0181). De 2011 a 2018, cinco eventos no SNP ocorreram entre pacientes sem terapia profilática, e nenhum ocorreu entre aqueles cobertos pela profilaxia (5/20 × 0/29, p=0,0081). Conclusões: A prevalência de complicações neurológicas em hemofílicos em nossa coorte é similar à de outros estudos. Assim como no SNC, a terapia profilática também reduz o risco de complicações no SNP. Este é o primeiro relato na literatura a mostrar esse benefício.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results